This is a Phase 1/2 multicenter, open-label, single dose trial of 4D-710 investigational gene therapy in adults with cystic fibrosis.
- Investigator
- Cesar A Trillo-Alvarez
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Research at a glance
Top areas of exploration
- Acute Lung Injury , 2 publications
- Respiratory Distress Syndrome , 2 publications
- Critical Illness , 2 publications
- Anti-Bacterial Agents , 1 publications
Research activity
Active clinical trials
The purpose of this study is to evaluate the safety, and tolerability and efficacy of VX-522 in participants 18 years of age and older with cystic fibrosis and a cystic fibrosis transmembrane conductance regulator (CFTR) genotype not responsive to…
- Investigator
- Cesar A Trillo-Alvarez
- Status
- Accepting Candidates
- Ages
- 18 Years - 64 Years
- Sexes
- All
My publications
Filter publications
12 publications
2011
Acute lung injury prediction score: derivation and validation in a population-based sample.
The European respiratory journal
•2011
Epidemiology of critical care syndromes, organ failures, and life-support interventions in a suburban US community.
Chest
•2011
Long-term survival in patients with tracheostomy and prolonged mechanical ventilation in Olmsted County, Minnesota.
Respiratory care
•2011
Mapping physicians' admission diagnoses to structured concepts towards fully automatic calculation of acute physiology and chronic health evaluation score.
BMJ open
•2010
Towards the prevention of acute lung injury: a population based cohort study protocol.
BMC emergency medicine
•